Article
GNLY gene polymorphism: A potential role in understanding psoriasis pathogenesis.
Journal of cosmetic dermatology - 1 Oct 2022
Khalid Hesham Nabil, Elghobashy Yasser Abd Elsattar, Elsayed Asmaa Nagy
Abstract excerpt
BACKGROUND: Psoriasis is a chronic inflammatory illness that affects 2%-3% of the world's population. Granulysin (GNLY), along with granzyme and perforin, is a cytolytic antimicrobial peptide (AMP) released from the granules of both natural killer (NK) cells and cytotoxic T lymphocytes (CTLs). By immunohistochemistry, it has been shown that GNLY expression increases in psoriasis lesions. AIMS: Our work aimed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
